Research Article

Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus

Table 3

Factor analysis of 25 acylcarnitines resulted in factors and the postrotation load of each factor.

VariablesFactor 1Factor 2Factor 3Factor 4Factor 5Factor 6

C220.7880.1530.152-0.0280.141-0.095
C260.7630.177-0.0070.032-0.0570.037
C240.716-0.0400.0780.1610.0080.174
C14DC0.6580.1680.139-0.0480.098-0.169
C200.653-0.1550.1260.3680.0540.181
C4DC0.625-0.0470.0400.0480.0580.353
C16:1-OH0.6030.2380.1540.1720.150-0.010
C14:10.5430.0420.5310.0420.2900.068
C5:10.5410.1000.065-0.0290.2920.475
C14-OH0.518-0.0760.1490.1180.3710.079
C20.0340.7750.1660.065-0.087-0.133
C3-0.0050.753-0.0490.2230.0410.092
C50.0960.7130.044-0.0870.0130.231
C40.2200.6680.1760.2070.0330.083
C80.1220.1310.8350.1320.0300.095
C100.087-0.0740.7910.3280.1210.128
C5DC0.2570.2440.523-0.0480.120-0.068
C180.2220.0730.0710.8230.0860.000
C160.1060.4440.1550.6640.063-0.111
C00.0190.2820.0690.4970.0610.404
C120.0350.1290.0450.0930.7560.090
C16-0H0.249-0.0530.074-0.0560.696-0.037
C140.085-0.0410.0770.4070.6010.157
C60.0330.2350.049-0.092-0.0250.526
C5-0H0.5020.060-0.0580.2890.1810.512